Previous studies showed that miR-612 inhibited the capacity of tumorigenesis and metastasis of HCC by targeting AKT2.21, 22 Here we extended these findings to CRC occurrence and development, the underlying mechanism of which in not new. This evidence concerns the gene AKT2 and hepatocellular carcinoma.